NewslettersHematopoiesis NewsSLIT2 Promoter Hypermethylation Predicts Disease Progression in Chronic Myeloid LeukemiaBy Noshin Noorjahan - November 22, 20220243The level of SLIT2 promoter methylation was determined in 104 chronic myeloid leukemia patients, and its clinical significance was analyzed.[European Journal of Medical Research]Full Article